Immunome Inc. (IMNM)
NASDAQ: IMNM
· Real-Time Price · USD
11.59
1.44 (14.13%)
At close: Sep 26, 2025, 3:59 PM
Immunome Revenue
Immunome reported an annual revenue of $9.04M, reflecting a -35.5% growth. For the quarter ending June 30, 2025, Immunome generated $4.01M in revenue.
Revenue (ttm)
9.04M
Revenue Growth
-35.5%
Price / Sales Ratio
68.88
Revenue / Employee
69.02K
Employees
131
Market Cap
1.01B
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 9.04M | -35.50% |
| Dec 31, 2023 | 14.02M | +Infinity% |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |